Clinical trial
Nicotine Lozenge to Reduce Smokeless Tobacco Use
NCT00218283 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00218283 |
|---|---|
| Title | Nicotine Lozenge to Reduce Smokeless Tobacco Use |
| Official title | Treatment of Smokeless Tobacco Users |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | University of Minnesota |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tobacco Use Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Nicotine Lozenge, Behavioral Counseling |
| Enrollment | 100 |
| Start date | Jan 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: